Stevanato Group S.p.A.

STVN

IT0005452658

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 01:30:02 15/06/2024 am IST			5-day change	1st Jan Change
17.77 ^USD	-2.90%		-4.56%	-34.88%

30/05	Stevanato Group Inaugurates New Pharma Factory Near Rome	MT
30/05	Stevanato Group Unveils New Plant in Cisterna Di Latina for the Production of Pre-Sterilized Ez-Fill® Syringes and Cartridges	CI

Stevanato Group S.p.A. Approves Board Appointments

May 25, 2024 at 01:40 am IST

Stevanato Group S.p.A. at its Annual General Meeting of Shareholders held on May 22, 2024 approved the appointment of Karen Flynn and Luciano Santel to the board of Directors of the company.

Latest news about Stevanato Group S.p.A.

Stevanato Group Inaugurates New Pharma Factory Near Rome	30/05	MT
Stevanato Group Unveils New Plant in Cisterna Di Latina for the Production of Pre-Sterilized Ez-Fill® Syringes and Cartridges	30/05	CI
Stevanato Appoints Franco Stevanato as Chief Executive Officer	28/05	MT
Stevanato Group S.P.A. Announces Chief Executive Officer Changes	28/05	CI
Stevanato Group S.p.A. Approves Dividend for the Year Ended December 31, 2023	25/05	CI
Stevanato Group S.p.A. Approves Board Appointments	25/05	CI
Certain Common Stock of Stevanato Group S.p.A. are subject to a Lock-Up Agreement Ending on 21-MAY-2024.	21/05	CI
Transcript : Stevanato Group S.p.A. Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM	15/05
Morgan Stanley Lowers Price Target on Stevanato Group to $26 From $30, Keeps Equalweight Rating	13/05	MT
UBS Adjusts Stevanato Price Target to $24 From $34, Maintains Neutral Rating	10/05	MT
Sector Update: Health Care Stocks Higher Late Afternoon	10/05	MT
Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading	09/05	MT
Stevanato's Q1 Adjusted Earnings, Revenue Fall; 2024 Guidance Cut; Shares Fall 22%	09/05	MT
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	09/05	MT
Sector Update: Health Care	09/05	MT
Transcript : Stevanato Group S.p.A., Q1 2024 Earnings Call, May 09, 2024	09/05
Stevanato's Q1 Adjusted Earnings, Revenue Fall; 2024 Guidance Cut	09/05	MT
Stevanato Group S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
Stevanato Group S.P.A. Provides Revenue Guidance for 2024	09/05	CI
BNP Paribas Exane Initiates Stevanato Group With Outperform Rating	22/04	MT
Stevanato Group Names Ugo Gay as Chief Operations Officer	04/04	MT
Stevanato Group S.p.A. Announces the Appointment of Ugo Gay as Chief Operations Officer	04/04	CI
Stevanato Group Closes $379.7 Million Public Share Offering	27/03	MT
Stevanato Group Prices Upsized $330 Million Public Share Offering; Shares Rise	22/03	MT
Sector Update: Health Care Stocks Steady Pre-Bell Friday	22/03	MT

Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.

Sector

Medical Equipment, Supplies & Distribution

Calendar

15/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Stevanato Group S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.77 USD

Average target price

28.66 USD

Spread / Average Target

+61.30%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
STEVANATO GROUP S.P.A.	-34.88%	4.85B
ABBOTT LABORATORIES	-5.81%	180B
MEDTRONIC PLC	-1.63%	106B
BECTON, DICKINSON AND COMPANY	-4.14%	67.55B
DEXCOM, INC.	-6.56%	46.11B
CENCORA, INC.	+13.22%	45.79B
HOYA CORPORATION	+4.23%	41.61B
METTLER-TOLEDO INTERNATIONAL, INC.	+19.93%	31.07B
TERUMO CORPORATION	+10.84%	24.77B
WEST PHARMACEUTICAL SERVICES, INC.	-5.36%	24.27B

Other Medical Equipment, Supplies & Distribution